Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7822155rdf:typepubmed:Citationlld:pubmed
pubmed-article:7822155lifeskim:mentionsumls-concept:C0042776lld:lifeskim
pubmed-article:7822155lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:7822155lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:7822155lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:7822155lifeskim:mentionsumls-concept:C0087048lld:lifeskim
pubmed-article:7822155lifeskim:mentionsumls-concept:C1524063lld:lifeskim
pubmed-article:7822155pubmed:issue1lld:pubmed
pubmed-article:7822155pubmed:dateCreated1995-2-14lld:pubmed
pubmed-article:7822155pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7822155pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7822155pubmed:abstractTextTo understand better the immunopathology of HTLV-I uveitis by investigating the clonality of HTLV-I-infected T-cell clones.lld:pubmed
pubmed-article:7822155pubmed:languageenglld:pubmed
pubmed-article:7822155pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7822155pubmed:citationSubsetIMlld:pubmed
pubmed-article:7822155pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7822155pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7822155pubmed:statusMEDLINElld:pubmed
pubmed-article:7822155pubmed:monthJanlld:pubmed
pubmed-article:7822155pubmed:issn0146-0404lld:pubmed
pubmed-article:7822155pubmed:authorpubmed-author:MochizukiMMlld:pubmed
pubmed-article:7822155pubmed:authorpubmed-author:ItohKKlld:pubmed
pubmed-article:7822155pubmed:authorpubmed-author:SagawaKKlld:pubmed
pubmed-article:7822155pubmed:authorpubmed-author:OizumiKKlld:pubmed
pubmed-article:7822155pubmed:authorpubmed-author:MasuokaKKlld:pubmed
pubmed-article:7822155pubmed:issnTypePrintlld:pubmed
pubmed-article:7822155pubmed:volume36lld:pubmed
pubmed-article:7822155pubmed:ownerNLMlld:pubmed
pubmed-article:7822155pubmed:authorsCompleteYlld:pubmed
pubmed-article:7822155pubmed:pagination254-8lld:pubmed
pubmed-article:7822155pubmed:dateRevised2010-3-24lld:pubmed
pubmed-article:7822155pubmed:meshHeadingpubmed-meshheading:7822155-...lld:pubmed
pubmed-article:7822155pubmed:meshHeadingpubmed-meshheading:7822155-...lld:pubmed
pubmed-article:7822155pubmed:meshHeadingpubmed-meshheading:7822155-...lld:pubmed
pubmed-article:7822155pubmed:meshHeadingpubmed-meshheading:7822155-...lld:pubmed
pubmed-article:7822155pubmed:meshHeadingpubmed-meshheading:7822155-...lld:pubmed
pubmed-article:7822155pubmed:meshHeadingpubmed-meshheading:7822155-...lld:pubmed
pubmed-article:7822155pubmed:meshHeadingpubmed-meshheading:7822155-...lld:pubmed
pubmed-article:7822155pubmed:meshHeadingpubmed-meshheading:7822155-...lld:pubmed
pubmed-article:7822155pubmed:meshHeadingpubmed-meshheading:7822155-...lld:pubmed
pubmed-article:7822155pubmed:meshHeadingpubmed-meshheading:7822155-...lld:pubmed
pubmed-article:7822155pubmed:meshHeadingpubmed-meshheading:7822155-...lld:pubmed
pubmed-article:7822155pubmed:meshHeadingpubmed-meshheading:7822155-...lld:pubmed
pubmed-article:7822155pubmed:year1995lld:pubmed
pubmed-article:7822155pubmed:articleTitlePolyclonal use of T-cell receptor alpha for human T-cell lymphotropic virus type 1-infected T cells.lld:pubmed
pubmed-article:7822155pubmed:affiliationDepartment of Immunology, Kurume University School of Medicine, Japan.lld:pubmed
pubmed-article:7822155pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7822155pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed